PATENT CLAIM ANALYSIS

Application Number: 16118909
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["424", "141100"]

Abstract:
This disclosure describes, in one aspect, a composition that includes a β-glucan component and an antibody component that specifically binds to the β-glucan. In another aspect, this disclosure describes a method of increasing a subject's response to β-glucan immunotherapy. Generally, the method includes identifying the subject as a low binder of β-glucan and administering to the subject a composition that comprises a β-glucan moiety conjugated to the therapeutic antibody. In some cases, the therapeutic antibody can be an anti-tumor antibody.

Claim (Index 1):
A composition comprising:\n a soluble \u03b2-glucan component; and an antibody component that specifically binds to the soluble \u03b2-glucan.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 96.0
- Lexical Diversity: 1.95652
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14398020', '15845421', '14116550', '14123624', '15386887']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7392246968864009
- 35 USC 102 Novelty (BERT): 0.5640303516578574
- Combined Prediction Score: 0.7217052623635466
- Mean Citation Score: 340.2255100000001
- Max Citation Score: 464.75598
- Similarity Product: 363.5507886049605

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test